ENFR
Collaborate

Built cores, open edges.

Every project on this site has a working core — a live map, a running demo, an operating advisory practice — and one edge where it needs someone we haven't met yet. EUROSTROKES is founder-led: what follows was built by one vascular neurologist, and if you write, he is the one who answers. These are the asks, stated plainly.

Door 1

For stroke clinicians

Ask 1The European stroke-network map.

The core exists: every recanalisation centre in Attica — 19 centres, IVT and EVT capability, sector, availability class — mapped and live in three languages. One region proves the method. The value appears when a stroke physician can see any network a patient might move through. If you know your region's stroke pathways — which centres treat, what their real availability is, where transfers actually break down — we want to build your region's layer with you. Contributed layers are verified against the published data standard before going live, and the contributor is credited as the named author of their region's layer.

Regional layers are accepted against a minimal published data standard — fields, sourcing, verification. Authorship credit attaches on acceptance, and a layer can be revised or retired on data-quality grounds.

Open questionThe map works for one region. What breaks when we map yours?

Map your region with us

Ask 2Test the LiveTextbook demo.

The core runs: an evidence corpus for acute stroke in which every statement traces to the trial that produced it — no orphan claims, no invented citations, verification built in rather than promised. It works for the people who built it; that is the weakest possible evidence. We need vascular neurologists and stroke physicians to run cases against the demo — anonymised numerical case profiles only, no images, no patient identifiers — and tell us, bluntly, where it breaks.

Open questionDoes traceability survive contact with a clinician who didn't build it?

Break the demo — send a case

For stroke physicians and vascular neurologists only. This is not a route for personal medical questions; if you are a patient or a relative, do not use this address. The demo does not run anonymously, and it is not a clinical service. Every case is reviewed and approved by the administrator before it runs; responses may take several days. Never use this for a live clinical decision — for acute stroke, follow your local pathway.

Your case must contain no images and no patient-identifying data, and it must be retrospective — not an active patient awaiting a decision.

Send your case

Running until 16 September 2026: the gray-zone decision study — the same constructed cases, put to many physicians at once, so each participant can see where their own judgement sits.

Door 2

For stroke-technology companies

AskA clinician in the design loop, not in the brochure.

This is the operating arm of EUROSTROKES: advisory for imaging-AI and stroke-technology companies on workflow fit, pilot and study design, KPI architecture, and the clinical framing between the number and the decision. Imaging AI now quantifies a stroke in seconds; the decision still happens in a human head, under time pressure, with the patient in front of it. If you are building in this space and want a practising vascular neurologist embedded in the design loop rather than quoted at the end, start the conversation — the first one is about your product, not our fee.

The question we will ask youWhere exactly, between the quantified scan and the decision, does your tool lose the clinician?

Start the conversation
Door 3

For statisticians and methodologists

AskReproduce one number, on the record.

The Bayesian Centre publishes one Reading a month: one published stroke paper, one clinical question, one probability against a decision line fixed before the arithmetic ran, with the counts, the seeded script, the execution log and the reconciliation between engines published beside it. The invitation is open to anyone with the credentials to take it up — statisticians, methodologists, epidemiologists, clinicians who work with these methods: take an afternoon, reproduce the headline probability by whatever method you trust, and write back saying whether you agree, with your name and affiliation. The same door is open to a biostatistician who wants to work on the Centre's re-analyses rather than check them.

Open questionDoes the arithmetic reproduce from the paper's own counts, by a method the checker trusts?

Read the terms of the open check

Before you write: EUROSTROKES holds no vendor equity and takes no commissions. The full independence policy is in How We Work.

There is no forum here — deliberately. Ideas move by direct conversation, and at the meetings where stroke physicians already gather. When live collaborations exist, a standing venue will follow them, not precede them.

The projects on this site are built — and each has one open edge.

EUROSTROKES is looking for the people who belong on those edges: clinicians who treat stroke, and companies building tools for them.

Clinical rigor, translated into systems that work.

For technology partners, this means evidence that can be traced, structured and used. For hospitals and networks, it means pathways that can be assessed, modelled and improved.

Open door A door standing open in outline, with a plane of light falling in beside it and a single teal handle. Clinicians

Stage: demo running (internal) · corpus growing

Does traceability survive contact with a clinician who didn't build it?

Vascular neurologists to run anonymised cases against the demo and report where it breaks.

Open door A door standing open in outline, with a plane of light falling in beside it and a single teal handle. Hospitals and networks

Network Optimization

EUROSTROKES helps stroke systems see the whole pathway—from first contact and transfer patterns to treatment capability, standards and the operating gaps between them.

Open door A door standing open in outline, with a plane of light falling in beside it and a single teal handle. Technology partners

Evidence Corpus

LiveTextbook is a source-attributed clinical reasoning layer: evidence organised around the decision a clinician actually faces, with provenance and uncertainty visible by construction.

Each door opens and closes in place. Nothing you choose here is stored or sent — it stays in this browser tab.

Start with the right question

Evidence product or stroke network?

For evidence-corpus licensing, clinical-technology advisory, network assessment, research collaboration or teaching, write directly.

Choose the right contact route